Status:
RECRUITING
Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier
Lead Sponsor:
Prof. Patrick Petignat
Conditions:
Cervical Cancer
HPV
Eligibility:
FEMALE
30-49 years
Phase:
NA
Brief Summary
Cervical cancer remains a major public health challenge in low- and middle-income countries (LMICs) due to financial and logistical issues. The World Health Organization (WHO) recommendation for cervi...
Eligibility Criteria
Inclusion
- Free and informed consent to take part in the study on a voluntary basis
Exclusion
- No initiation of sexual intercourse
- Pregnancy at the screening consultation
- Any condition altering the cervix visualization at the screening consultation (e.g. heavy vaginal bleeding)
- History of anogenital cancer or known anogenital cancer at the screening consultation
- Previous hysterectomy
- Not sufficiently healthy to participate in the study
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
5886 Patients enrolled
Trial Details
Trial ID
NCT04859530
Start Date
August 1 2018
End Date
September 30 2025
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dschang District Hospital
Dschang, Menoua, Cameroon